| Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. JJ Sekelsky, SJ Newfeld, LA Raftery, EH Chartoff, WM Gelbart Genetics 139 (3), 1347-1358, 1995 | 956 | 1995 |
| Sex differences in neural mechanisms mediating reward and addiction JB Becker, E Chartoff Neuropsychopharmacology 44 (1), 166-183, 2019 | 444 | 2019 |
| Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation WA Carlezon Jr, EH Chartoff Nature protocols 2 (11), 2987-2995, 2007 | 434 | 2007 |
| Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-β responsive cells SJ Newfeld, EH Chartoff, JM Graff, DA Melton, WM Gelbart Development 122 (7), 2099-2108, 1996 | 217 | 1996 |
| Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens SR Ebner, MF Roitman, DN Potter, AB Rachlin, EH Chartoff Psychopharmacology 210, 241-252, 2010 | 192 | 2010 |
| It’s MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system EH Chartoff, HS Connery Frontiers in pharmacology 5, 116, 2014 | 175 | 2014 |
| Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats E Chartoff, A Sawyer, A Rachlin, D Potter, A Pliakas, WA Carlezon Neuropharmacology 62 (1), 167-176, 2012 | 170 | 2012 |
| NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala PJ Kenny, E Chartoff, M Roberto, WA Carlezon, A Markou Neuropsychopharmacology 34 (2), 266-281, 2009 | 160 | 2009 |
| Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice MR Adams, EP Brandon, EH Chartoff, RL Idzerda, DM Dorsa, ... Proceedings of the National Academy of Sciences 94 (22), 12157-12161, 1997 | 151 | 1997 |
| Sex differences in kappa opioid receptor function and their potential impact on addiction EH Chartoff, M Mavrikaki Frontiers in neuroscience 9, 466, 2015 | 146 | 2015 |
| Early life stress disrupts social behavior and prefrontal cortex parvalbumin interneurons at an earlier time-point in females than in males FH Holland, P Ganguly, DN Potter, EH Chartoff, HC Brenhouse Neuroscience letters 566, 131-136, 2014 | 142 | 2014 |
| Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression JJ Cone, EH Chartoff, DN Potter, SR Ebner, MF Roitman PloS one 8 (3), e58251, 2013 | 125 | 2013 |
| Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists EH Chartoff, CL Heusner, RD Palmiter Neuropsychopharmacology 30 (7), 1324-1333, 2005 | 123 | 2005 |
| Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation EH Chartoff, BT Marck, AM Matsumoto, DM Dorsa, RD Palmiter Proceedings of the National Academy of Sciences 98 (18), 10451-10456, 2001 | 122 | 2001 |
| Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats SE Russell, AB Rachlin, KL Smith, J Muschamp, L Berry, Z Zhao, ... Biological psychiatry 76 (3), 213-222, 2014 | 110 | 2014 |
| The kappa-opioid agonist U69, 593 blocks cocaine-induced enhancement of brain stimulation reward HC Tomasiewicz, MS Todtenkopf, EH Chartoff, BM Cohen, ... Biological psychiatry 64 (11), 982-988, 2008 | 108 | 2008 |
| Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity DN Potter, D Damez-Werno, WA Carlezon Jr, BM Cohen, EH Chartoff Biological psychiatry 70 (8), 744-753, 2011 | 103 | 2011 |
| Oxycodone self-administration in male and female rats M Mavrikaki, M Pravetoni, S Page, D Potter, E Chartoff Psychopharmacology 234, 977-987, 2017 | 100 | 2017 |
| Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue EH Chartoff, M Papadopoulou, ML MacDonald, A Parsegian, D Potter, ... Molecular pharmacology 75 (3), 704-712, 2009 | 98 | 2009 |
| Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal EH Chartoff, SD Mague, MF Barhight, AM Smith, WA Carlezon Journal of Neuroscience 26 (24), 6450-6457, 2006 | 93 | 2006 |
William A. Carlezon Jr. Harvard Medical School確認したメール アドレス: mclean.harvard.edu
